
浏览全部资源
扫码关注微信
1.江西中医药大学药学院,南昌 330004
2.南昌 医学院药学院,南昌 330052
硕士研究生。研究方向:中药资源开发与利用。E-mail:473172049@qq.com
教授,博士生导师,博士。研究方向:中药资源与中药炮制。E-mail:55925368@qq.com
收稿日期:2025-02-28,
修回日期:2025-06-20,
录用日期:2025-06-28,
纸质出版日期:2025-08-30
移动端阅览
马鑫莹,许瑞娜,李勺玄,等.基于肠道菌群和代谢组学的芜菁多糖改善小鼠酒精性肝损伤机制研究[J].中国药房,2025,36(16):2005-2011.
MA Xinying,XU Ruina,LI Shaoxuan,et al.Study on the mechanism of Brassica rapa polysaccharide in improving alcoholic liver injury of mice based on intestinal microbiota and metabolomics[J].ZHONGGUO YAOFANG,2025,36(16):2005-2011.
马鑫莹,许瑞娜,李勺玄,等.基于肠道菌群和代谢组学的芜菁多糖改善小鼠酒精性肝损伤机制研究[J].中国药房,2025,36(16):2005-2011. DOI: 10.6039/j.issn.1001-0408.2025.16.09.
MA Xinying,XU Ruina,LI Shaoxuan,et al.Study on the mechanism of Brassica rapa polysaccharide in improving alcoholic liver injury of mice based on intestinal microbiota and metabolomics[J].ZHONGGUO YAOFANG,2025,36(16):2005-2011. DOI: 10.6039/j.issn.1001-0408.2025.16.09.
目的
2
研究芜菁多糖(BRP)对酒精性肝损伤小鼠肝组织中Toll样受体4(TLR4)/髓样分化因子88(MyD88)/核因子κB(NF-κB)、AMP活化蛋白激酶(AMPK)/固醇调节元件结合蛋白1c(SREBP-1c)信号通路,肠道菌群和肝脏代谢的影响,初步阐明其改善酒精性肝损伤的机制。
方法
2
将 72只小鼠随机分为空白组(生理盐水)、模型组(生理盐水)、联苯双酯组(阳性对照,300 mg/kg)和BRP低、中、高剂量组(75、150、300 mg/kg),每天灌胃给药1次,连续9 d。末次给药后,除空白组外的其余各组小鼠均灌胃白酒建立酒精性肝损伤模型。检测小鼠血清中丙氨酸转氨酶、天冬氨酸转氨酶以及肝组织中总胆固醇、甘油三酯、低密度脂蛋白胆固醇、白细胞介素6、白细胞介素1β、肿瘤坏死因子α、脂多糖水平和TLR4、MyD88、NF-κB p65、磷酸化NF-κB p65(p-NF-κB 65)、AMPK、磷酸化AMPK(p-AMPK)、SREBP-1c的蛋白表达水平;观察肝组织和结肠组织病理形态学变化。利用16S rRNA技术检测小鼠肠道菌群的变化,利用代谢组学技术检测肝脏代谢物的变化。
结果
2
与模型组比较,BRP各剂量组小鼠上述生化指标和肝组织中TLR4、MyD88、p-NF-κB p65、SREBP-1c的蛋白表达水平均显著降低(
P
<0.05或
P
<0.01),p-AMPK的蛋白表达水平均显著升高(
P
<0.05或
P
<0.01);肝组织和结肠组织病理损伤均显著改善。中剂量BRP可在一定程度上升高小鼠肠道内容物中艾克曼菌属、
norank_f_Muribaculaceae、Lachnospiraceae_NK4A136_group
等的相对丰度,降低乳杆菌属的相对丰度和大肠埃希菌属-志贺菌属的相对丰度;代谢组学共鉴定出尿黑酸、肉豆蔻酰溶血磷脂酰胆碱等9个差异代谢物,涉及酪氨酸代谢等通路。
结论
2
BRP可回调有益菌群的相对丰度、降低有害菌群的相对丰度,改善肠道菌群结构,减少促炎介质脂多糖进入肝组织,影响肝脏中酪氨酸代谢等代谢通路和TLR4/MyD88/NF-κB、AMPK/SREBP-1c信号通路的表达,最终改善酒精性肝损伤。
OBJECTIVE
2
To investigate the effects of
Brassica rapa
polysaccharide (BRP) on the Toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88)/nuclear factor-κB (NF-κB), AMP-activated protein kinase (AMPK)/sterol regulatory element-binding protein-1c (SREBP-1c) pathways, intestinal microbiota and liver metabolism of mice with alcoholic liver injury, and preliminarily elucidate its mechanism for improving alcoholic liver injury.
METHODS
2
Seventy-two mice were randomly divided into blank group (normal saline), model group (normal saline), bifendate group (positive control, 300 mg/kg) and BRP low-, medium- and high-dose groups (75, 150 and 300 mg/kg). They were given relevant medicine intragastrically, once a day, for consecutive 9 d. After the last administration, mice in all groups except the blank group were gavaged with white liquor to establish an alcoholic liver injury model. The levels of alanine aminotransferase and aspartate aminotransferase in serum, total cholesterol, triglycerides, low-density lipoprotein cholesterol, interleukin-6, interleukin-1β, tumor necrosis factor-α and lipopolysaccharide, as well as protein expressions of TLR4, MyD88, NF-κB p65, phosphorylated NF-κB p65 (p-NF-κB p65), AMPK, phosphorylated AMPK (p-AMPK), and SREBP-1c were all detected; pathological morphological changes of liver tissue and colon were observed. 16S rRNA was used to detect the changes of intestinal microbiota in mice, and metabolomics technology was used to detect the changes of liver metabolites.
RESULTS
2
Compared with model group, the above biochemical indicators and the protein expressions of TLR4, MyD88, p-NF-κB p65, and SREBP-1c in liver tissues were all significantly decreased (
P
<0.05 or
P
<0.01), while the protein expression of p-AMPK was significantly increased (
P
<0.05 or
P
<0.01). Pathological damage to liver and colon tissues was significantly improved. Medium dose of BRP could increase the relative abundance of
Akkermansia
,
norank_f_Muribaculaceae
and
Lachnospiraceae_NK4A136
_
group
in the intestinal contents of mice to a certain extent, and decrease the relative abundance of
Lactobacillus
and
Escherichia-Shigella
. A total of 9 differential metabolites were identified by metabolomics, including homogentisic acid, myristyl lysophosphatidylcholine, which were involved in pathways such as tyrosine metabolism.
CONCLUSIONS
2
BRP can regulate the relative abundance of beneficial flora, reduce the relative abundance of harmful flora, improve the structure of intestinal colonies, reduce the entry of pro-inflammatory mediator lipopolysaccharides into liver tissue, affect metabolic pathways such as tyrosine metabolism and the expression of TLR4/MyD88/NF-κB and AMPK/SREBP-1c signaling pathways in the liver, and ultimately improve alcoholic liver injury.
WU X Q , FAN X D , MIYATA T , et al . Recent advances in understanding of pathogenesis of alcohol-associated liver disease [J ] . Annu Rev Pathol , 2023 , 18 : 411 - 438 .
AVILA M A , DUFOUR J F , GERBES A L , et al . Recent advances in alcohol-related liver disease(ALD):summary of a gut round table meeting [J ] . Gut , 2020 , 69 ( 4 ): 764 - 780 .
JOPHLIN L L , SINGAL A K , BATALLER R , et al . ACG clinical guideline:alcohol-associated liver disease [J ] . Am J Gastroenterol , 2024 , 119 ( 1 ): 30 - 54 .
孙思邈 . 备急千金要方:三十卷 [M ] . 影印本. 北京 : 人民卫生出版社 , 1982 : 448 .
张涛 , 安熙强 , 程江南 , 等 . 维药恰玛古的化学成分及生物活性研究进展 [J ] . 中国药房 , 2017 , 28 ( 7 ): 982 - 986 .
陈文彬 . 维药恰玛古多糖提取工艺、结构表征及生物活性的研究 [D ] . 南昌 : 江西中医药大学 , 2020 .
ALBILLOS A , DE GOTTARDI A , RESCIGNO M . The gut-liver axis in liver disease:pathophysiological basis for therapy [J ] . J Hepatol , 2020 , 72 ( 3 ): 558 - 577 .
臧月 , 王生 , 刘楠 , 等 . 肠道菌群失调介导酒精性肝病发生发展的机制研究进展 [J ] . 中国药理学通报 , 2016 , 32 ( 4 ): 451 - 455 .
KIM D K , RAJAN P , CUONG D M , et al . Melosira nummuloides ethanol extract ameliorates alcohol-induced liver injury by affecting metabolic pathways [J ] . J Agric Food Chem , 2024 , 72 ( 15 ): 8476 - 8490 .
邵仕娟 , 王浩 , 史雯馨 , 等 . 基于代谢组学探究葛根素对慢性酒精性肝损伤小鼠的保护作用 [J ] . 食品工业科技 , 2024 , 45 ( 16 ): 25 - 35 .
刘琳 , 图力古尔 . 金毛鳞伞子实体粗多糖对小鼠酒精性肝损伤的保护作用 [J ] . 食用菌学报 , 2022 , 29 ( 3 ): 50 - 57 .
李颖芝 . 杜仲叶多糖对急性酒精中毒小鼠的保护作用及解酒果冻产品开发 [D ] . 南昌 : 南昌大学 , 2024 .
翟明昊 , 秦光和 , 赵青剑 , 等 . 三七须根提取液对小鼠酒精性肝损伤的保护作用研究 [J ] . 食品安全质量检测学报 , 2025 , 16 ( 3 ): 220 - 225 .
LIU Z N , WU X , FANG Q , et al . CD73 attenuates alcohol-induced liver injury and inflammation via blocking TLR4/MyD88/NF-κB signaling pathway [J ] . J Inflamm Res , 2022 , 15 : 53 - 70 .
WAN W M , WEI R M , XU B L , et al . Qiwei jinggan ling regulates oxidative stress and lipid metabolism in alcoholic liver disease by activating AMPK [J ] . Phytomedicine , 2024 , 135 : 156125 .
黄桥深 , 张永康 , 汪水平 , 等 . 嗜黏蛋白阿克曼氏菌治疗疾病的潜力与作用机制研究进展 [J ] . 微生物学报 , 2023 , 63 ( 9 ): 3360 - 3373 .
ZENG S J , CAO J , WEI C X , et al . Polysaccharides from Artocarpus heterophyllus Lam.(jackfruit)pulp alleviate obesity by modulating gut microbiota in high fat diet-induced rats [J ] . Food Hydrocoll , 2023 , 139 : 108521 .
VACCA M , CELANO G , CALABRESE F M , et al . The controversial role of human gut Lachnospiraceae [J ] . Microorganisms , 2020 , 8 ( 4 ): 573 .
王静 , 臧帆 , 秦松 . 螺旋藻藻蓝蛋白对酒精性肝损伤大鼠肠道菌群的影响 [J ] . 海洋科学 , 2023 , 47 ( 12 ): 93 - 101 .
RIZZATTI G , LOPETUSO L R , GIBIINO G , et al . Proteobacteria:a common factor in human diseases [J ] . Biomed Res Int , 2017 , 2017 : 9351507 .
殷亭湄 , 杨必乾 , 付晓艳 , 等 . 基于LC-MS/MS代谢组学技术探讨甘草缓解顺铂肝损伤的作用机制 [J ] . 时珍国医国药 , 2024 , 35 ( 9 ): 2067 - 2071 .
王君 , 唐浩 , 尹艺晓 , 等 . 血府逐瘀汤及其各提取部位对高脂饮食诱导的代谢相关脂肪性肝病小鼠肝脏代谢物的影响 [J ] . 上海中医药杂志 , 2024 , 58 ( 8 ): 62 - 71 .
NAN W G , XIONG F , ZHENG H , et al . Myristoyl lysophosphatidylcholine is a biomarker and potential therapeutic target for community-acquired pneumonia [J ] . Redox Biol , 2022 , 58 : 102556 .
张旭 , 张晨晨 , 杨颖 , 等 . 基于代谢组学研究保利尔胶囊的调血脂作用 [J ] . 药物评价研究 , 2025 , 48 ( 1 ): 60 - 72 .
陈乐 , 倪玲凡 , 史静超 , 等 . 基于肝脏代谢组学研究龟龄集对轻度认知功能障碍大鼠肝保护作用 [J ] . 中草药 , 2025 , 56 ( 6 ): 1999 - 2008 .
0
浏览量
15
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
公网安备50010302001817